Journal of Drug Metabolism & Toxicology : Citations & Metrics Report
Articles published in Journal of Drug Metabolism & Toxicology have been cited by esteemed scholars and scientists all around the world. Journal of Drug Metabolism & Toxicology has got h-index 17, which means every article in Journal of Drug Metabolism & Toxicology has got 17 average citations.
Following are the list of articles that have cited the articles published in Journal of Drug Metabolism & Toxicology.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
Total published articles |
35 | 38 | 29 | 24 | 18 | 4 | 11 | 12 |
Conference proceedings |
0 | 0 | 18 | 10 | 0 | 0 | 35 | 43 |
Citations received as per Google Scholar, other indexing platforms and portals |
172 | 235 | 289 | 321 | 304 | 229 | 238 | 206 |
| Journal total citations count | 2623 |
| Journal impact factor | 14.27 |
| Journal 5 years impact factor | 11.69 |
| Journal cite score | 16.36 |
| Journal h-index | 17 |
| Journal h-index since 2019 | 12 |
Important citations (282)
In vitro and in vivo comparison of gemcitabine and the gemcitabine analog 1-(2'-deoxy-2'-fluoroarabinofuranosyl) cytosine (fac) in human orthotopic and genetically modified mouse pancreatic cancer models |
|
Hippo pathway mediates resistance to cytotoxic drugs |
|
Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer. |
|
Critical regulation of calcium signaling and nmda-type glutamate receptor in developmental neural toxicity |
|
Effects of silver nanoparticles on human and rat embryonic neural stem cells |
|
review on non-clinical studies |
|
Using domestic and free-ranging arctic canid models for environmental molecular toxicology research |
|
effects of azole fungicide on amphibian: review |
|
Inhibitory effect of jengkol leaf (pithecellobium jiringa) extract to inhibit candida albicans biofilm |
|
Safety assessment of drug metabolites:? characterization of chemically stable metabolites |
|
Plasma-pooling methods to increase throughput for in vivo pharmacokinetic screening |
|
Metabolites and safety: what are the concerns, and how should we address them? |
|
Obtaining exposures of metabolites in preclinical species through plasma pooling and quantitative nmr: addressing metabolites in safety testing (mist) guidance without using radiolabeled compounds and chemically synthesized metabolite standards. |
|
Seeing through the mist: abundance versus percentage. commentary on metabolites in safety testing. |
|
metabolites in safety testing (mist): considerations of mechanisms of toxicity with dose, abundance, and duration of treatment. |
|
Which human metabolites have we mist? retrospective analysis, practical aspects, and perspectives for metabolite identification and quantification in pharmaceutical development. |
|
a simple model predicts ugt-mediated metabolism. |
|
Metabolic syndromes in endocrine system |
|
Metabolomics: the future of systems biology |
|
drug resistance and the prevention strategies in food borne bacteria: an update review. |
|